Show simple item record

dc.contributor.advisorKane, Robert R.
dc.contributor.authorQuintana, Jeremy M.
dc.contributor.otherBaylor University.en_US
dc.date.accessioned2015-06-24T15:57:35Z
dc.date.available2015-06-24T15:57:35Z
dc.date.copyright2015
dc.identifier.urihttp://hdl.handle.net/2104/9416
dc.description.abstractThe search for better, more effective vaccines has been an intriguing subject of research since the days of Jenner and the first smallpox vaccine. We have proposed a method of overcoming the weaknesses of current vaccines by taking advantage of a specific pathway of the adaptive immune response. This pathway uses the stimulation of an internalized toll-like receptor, which is found in dendritic cells, to promote an antiviral response to a specific pathogen. For this method to work, we must attach our toll-like receptor agonist and a target antigen to an antibody for delivery to the dendritic cell. This thesis includes both the development of the synthesis of the agonist, as well as the chemistry used to conjugate the agonist to the antibody.en_US
dc.language.isoen_USen_US
dc.rightsBaylor University projects are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. Contact libraryquestions@baylor.edu for inquiries about permission.en_US
dc.subjectVaccines.en_US
dc.subjectAntibody Conjugatesen_US
dc.subjectTLR7 Agonistsen_US
dc.titleDevelopment of TLR7 Agonist-Antibody Conjugatesen_US
dc.typeThesisen_US
dc.rights.accessrightsWorldwide access.en_US
dc.rights.accessrightsAccess changed 8/3/17.
dc.contributor.departmentBiochemistry.en_US
dc.contributor.schoolsHonors College.en_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record